Related Experiment Videos

Continuous negative extrathoracic pressure or continuous positive airway pressure for acute hypoxemic respiratory

P S Shah1, A Ohlsson, J P Shah

  • 1Department of Paediatrics and Department of Health Policy, Management and Evaluation, University of Toronto, Rm 775A, 600 University Avenue, Toronto, Ontario, Canada, M5G 1XB. pshah@mtsinai.on.ca

Insights

Continuous negative extrathoracic pressure ventilation (CNEP) and nasal continuous positive airway pressure (Ni-CPAP) show promise for treating pediatric acute hypoxemic respiratory failure (AHRF). Further research is needed to confirm their effectiveness and benefits in reducing complications.

Area of Science:

  • Pediatric critical care medicine
  • Respiratory physiology
  • Evidence-based medicine

Background:

  • Acute hypoxemic respiratory failure (AHRF) is a significant cause of mortality and morbidity in children.
  • Positive pressure ventilation is the standard treatment but carries risks of complications.
  • Non-invasive ventilation methods like CNEP and Ni-CPAP have shown potential benefits.

Purpose of the Study:

  • To evaluate the effectiveness of CNEP and Ni-CPAP in pediatric patients diagnosed with non-cardiogenic AHRF.
  • To compare these non-invasive methods against standard positive pressure ventilation.

Main Methods:

  • A systematic search of multiple databases (Cochrane, MEDLINE, EMBASE, CINAHL) and conference abstracts was conducted.
  • Included were randomized or quasi-randomized trials comparing CNEP or Ni-CPAP with standard therapy in children aged 1 month to 18 years with AHRF.
  • Study quality was assessed, and data were analyzed for effect sizes using relative risk (RR) and confidence intervals (CI).

Main Results:

  • One study involving 33 infants with bronchiolitis was identified.
  • The CNEP group showed a reduction in the fraction of inspired oxygen (FiO2) in four patients compared to none in the control group (RR 10.7, 95% CI 0.6-183.9).
  • Fewer infants in the CNEP group required intubation or positive pressure ventilation compared to the control group (RR 0.40, 95% CI 0.02-9.06).

Conclusions:

  • There is a significant lack of well-designed, controlled studies on non-invasive respiratory support for pediatric AHRF.
  • Further research is warranted to assess outcomes like reduced in-hospital mortality, avoidance of intubation, shorter hospital stays, and improved patient comfort.
Abstract

Related Concept Videos

Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation (NIPPV)
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...